Merck, GSK vaccine sales hit by pandemic as competitors' business booms

Merck, GSK vaccine sales hit by pandemic as competitors' business booms

Source: 
BioPharma Dive
News Tags: 
snippet: 

Sales of vaccines for shingles, human papillomavirus and bacterial pneumonia slowed considerably over the first three months of the year, according to financial results disclosed this week by Merck & Co. and GlaxoSmithKline.